IP Library Granted Patent US 11,007,332
Granted Patent B2
US 11,007,332 · App. 15/844,474 · Granted May 18, 2021

Nozzles for nasal drug delivery

Inventors: John D. Hoekman (Seattle, WA); Michael Hite (Normandy Park, WA); Alan Brunelle (Woodinville, WA); Joel Relethford (Everett, WA)
Assignee: IMPEL NEUROPHARMA, INC.
A61M15/08A61M15/0021A61M16/127B05B1/14B05B7/08A61M16/208A61M2202/064A61M2210/0612A61M2210/0618A61M2210/1067A61M2210/1475
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,007,332
App. No.
15/844,474
Granted
May 18, 2021
Kind
B2
Abstract

A nozzle for use in delivering a mixture of aerosol propellant and drug formulation. The nozzle includes a drug product inlet configured to receive a mixture of aerosolized propellant and an intranasal dosage form. The inlet is disposed at the proximal end. A nozzle body is secured to the drug product inlet. Two or more channels are disposed within the body. Two or more orifice apertures are disposed at the distal end of the nozzle.

Claims (22)

1. A method for delivering a compound to an upper olfactory region of a nasal cavity, the method comprising:

actuating a nozzle positioned for intranasal delivery of the compound to a subject, wherein actuating the nozzle pressurizes a proximal end of the nozzle, the nozzle including a propellant chamber housing a propellant and a compound chamber housing the compound and including a check shut off valve, a body of the nozzle defining a compound channel and a propellant channel, the compound channel being disposed within the propellant channel;

transporting the compound from the compound chamber and through the compound channel, the compound channel having a proximal end and a distal end, the proximal end being configured to receive the compound, the distal end of the compound channel having an outlet orifice exiting to the nasal cavity;

transporting a propellant from the propellant chamber and through the propellant channel, the propellant channel having a proximal end and a distal end, the proximal end being configured to receive the propellant, the distal end of the propellant channel having an outlet orifice exiting to the nasal cavity, and the propellant channel fluidly isolated from the compound channel;

preventing, by the check shut off valve, propellant from flowing through the compound channel once the compound is released from the compound chamber; and

releasing the compound from the outlet orifice of the compound channel and the propellant from the outlet orifice of the propellant channel directly into the nasal cavity, wherein once exited a respective outlet orifice, the compound and the propellant form a plume having a width of 5 degrees or less to enable the plume to reach the upper olfactory region of a nasal cavity.

2. The method of claim 1 , wherein the nozzle further includes at least a second compound channel, wherein the nozzle is capable of delivering more than one compound at a time.

3. The method of claim 1 , wherein the compound is a liquid, a powder, a gas, or combinations thereof.

4. The method of claim 1 , wherein the check shut off valve comprises a ball having a diameter smaller than a diameter of the compound chamber, and wherein the ball is made of plastic.

5. The method of claim 4 , wherein preventing the propellant from flowing through the compound channel comprises causing the ball to roll to the distal end of the compound channel to a location behind an opening of the nozzle thereby preventing the propellant from flowing through the compound channel.

6. The method of claim 1 , wherein the compound channel is centered within the propellant channel.

7. A method for delivering a compound to an upper olfactory region of a nasal cavity, the method comprising:

actuating a nozzle positioned for intranasal delivery of the compound to a subject, wherein actuating the nozzle pressurizes a proximal end of the nozzle, the nozzle including a propellant chamber housing a propellant and a compound chamber housing the compound, a body of the nozzle defining a compound channel and a propellant channel, the compound channel being disposed within the propellant channel;

transporting the compound from the compound chamber and through the compound channel, the compound channel having a proximal end and a distal end, the proximal end being configured to receive the compound from the compound chamber, the distal end of the compound channel having an outlet orifice exiting to the nasal cavity;

transporting a propellant from the propellant chamber and through the propellant channel, the propellant channel having a proximal end and a distal end, the proximal end being configured to receive the propellant from the propellant chamber, the distal end of the propellant channel having an outlet orifice exiting to the nasal cavity, and the propellant channel fluidly isolated from the compound channel;

preventing propellant from flowing through the compound channel once the compound is released from the compound chamber; and

releasing the compound from the outlet orifice of the compound channel and the propellant from the outlet orifice of the propellant channel directly into the nasal cavity, wherein once exited a respective outlet orifice, the compound and the propellant form a plume having a width of 5 degrees or less to enable the plume to reach the upper olfactory region of a nasal cavity.

8. The method of claim 7 , wherein the nozzle further includes at least a second compound channel, wherein the nozzle is capable of delivering more than one compound at a time.

9. The method of claim 7 , wherein the compound is a liquid, a powder, a gas, or combinations thereof.

10. The method of claim 7 , wherein preventing propellant from flowing through the compound channel comprises preventing by a check shut off valve, the check shut off valve comprising a ball having a diameter smaller than a diameter of the compound chamber, wherein the ball is made of plastic.

11. The method of claim 10 , wherein preventing propellant from flowing through the compound channel comprises causing the ball to roll to the distal end of the compound channel to a location behind an opening of the nozzle thereby preventing the propellant from flowing through the compound channel.

12. The method nozzle of claim 7 , wherein the compound channel is centered within the propellant channel.

Assignments (13)
SECURITY INTEREST Recorded Jun 5, 2025
From: WOODWARD SPECIALTY LLC
To: ALTER DOMUS (US) LLC
Reel/Frame 071324/0602 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2024
From: JN BIDCO LLC
To: WOODWARD SPECIALTY LLC
Reel/Frame 067062/0344 →
SECURITY INTEREST Recorded Mar 20, 2024
From: JN BIDCO LLC
To: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
Reel/Frame 066837/0144 →
RELEASE OF SECURITY INTEREST Recorded Feb 28, 2024
From: OAKTREE FUND ADMINISTRATION, LLC
To: IMPEL PHARMACEUTICALS, INC.
Reel/Frame 066699/0566 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2024
From: IMPEL PHARMACEUTICALS INC.
To: JN BIDCO LLC
Reel/Frame 066601/0479 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVAL OF APPLICATION NUMBERS 12866448 AND APLICATION NUMBER 14292481 PREVIOUSLY RECORDED AT REEL: 059790 FRAME: 0722. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 4, 2022
From: IMPEL NEUROPHARMA, INC.
To: IMPEL PHARMACEUTICALS INC.
Reel/Frame 059855/0252 →
CHANGE OF NAME Recorded Apr 25, 2022
From: IMPEL NEUROPHARMA, INC.
To: IMPEL PHARMACEUTICALS INC.
Reel/Frame 059790/0722 →
SECURITY INTEREST Recorded Mar 17, 2022
From: IMPEL NEUROPHARMA, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 059300/0433 →
SECURITY INTEREST Recorded Mar 17, 2022
From: IMPEL NEUROPHARMA, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 059300/0390 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER AND GRANT DATE WHICH WERE INADVERTENTLY SWITCHED FOR TWO PATENTS IN EXHIBIT A OF THE RELEASE OF SECURITY INTEREST PREVIOUSLY RECORDED AT REEL: 056758 FRAME: 0495. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST. Recorded Sep 14, 2021
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: IMPEL NEUOPHARMA, INC.
Reel/Frame 057683/0200 →
RELEASE OF SECURITY INTEREST Recorded Jul 6, 2021
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 056758/0495 →
SECURITY INTEREST Recorded Nov 5, 2020
From: IMPEL NEUROPHARMA, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
Reel/Frame 054287/0473 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2018
From: HOEKMAN, JOHN D.; HITE, MICHAEL; BRUNELLE, ALAN; RELETHFORD, JOEL
To: IMPEL NEUROPHARMA INC.
Reel/Frame 045866/0265 →
Continuity (4)
Division 14075126 · Nov 8, 2013
Continuation PCTUS2012037132 · May 9, 2012
Provisional Application 61484048 · May 9, 2011
Related Publication 20180126101A1 · May 10, 2018